secwatch.observer — SEC 8-K summary
======================================

Issuer:     CODEXIS, INC. (CDXS)
CIK:        0001200375
Form:       8-K
Filed at:   2022-12-20T23:59:59+00:00
Accession:  0001193125-22-309175
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Codexis appoints H. Stewart Parker to Board of Directors
--------------------------------------------------------

- H. Stewart Parker appointed as Class II director, term expiring at 2024 annual meeting.
- Appointed to Audit Committee and Strategic Committee; Board determined independent.
- Parker will receive annual cash retainer of $50,000, plus $20,000 Audit and $10,000 Strategic committee retainers.
- Granted 37,878 restricted stock units vesting over three years; future annual grants of $100,000 in RSUs.
- Parker brings biopharma leadership experience; currently on boards of IMPEL Pharmaceuticals and Sangamo Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1200375/000119312522309175/0001193125-22-309175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1200375/000119312522309175/d423687d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-309175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer